SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CYBR CyberCare the new look of healthcare
CYBR 467.82+4.0%Jan 7 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tadsamillionaire who wrote (1442)5/2/2000 11:37:00 AM
From: Jetter  Read Replies (1) of 3392
 
You guys catch Herb Greenbergs article this morning on CYBR?

Company not complying with FDA, promoting product it does not have approval for.

NYSE:EK already has competing product on market.

Here's a few more tidbits...

Now comes the first twist: A Washington, D.C., attorney who specializes in FDA regulations told Mark that even with the exemption, Cyber-Care's press releases go beyond what is normally considered acceptable. "If you are taking orders, that is starting the process of selling," he said. "And you cannot do that."

Twist No. 2: Later Friday Mark caught up with Bivins again. This time Bivins said there had been a misunderstanding about the Metcare agreement. After having had a chance to review the facts, he said the Metcare agreement doesn't concern a product that's awaiting FDA approval. That was actually "a low-end product," Bivins said.

Pretty good stuff. Makes CYBR seem very questionable and a pure pump...

Peace
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext